Cargando…
Knockdown of microRNA-130b improves doxorubicin sensitivity in bladder urothelial carcinoma by negatively regulating cylindromatosis expression
INTRODUCTION: Chemotherapeutic resistance reduces the sensitivity of bladder urothelial carcinoma (BUC) to chemotherapeutic drugs and contributes a barrier leading to treatment failure. The purpose of this research project is to investigate the regulatory effects of miR-130b on chemotherapeutic drug...
Autores principales: | Li, Bo, Zhang, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8314415/ https://www.ncbi.nlm.nih.gov/pubmed/34336031 http://dx.doi.org/10.5114/aoms.2019.86622 |
Ejemplares similares
-
Silenced Myeloblastosis Protein Suppresses Oral Tongue Squamous Cell Carcinoma via the microRNA-130a/Cylindromatosis Axis
por: Yang, Ran, et al.
Publicado: (2020) -
Silenced Myeloblastosis Protein Suppresses Oral Tongue Squamous Cell Carcinoma via the microRNA-130a/Cylindromatosis Axis [Retraction]
Publicado: (2021) -
MicroRNA-101-3p advances cisplatin sensitivity in bladder urothelial carcinoma through targeted silencing EZH2
por: Li, Bo, et al.
Publicado: (2019) -
miR-130b, an onco-miRNA in bladder cancer, is directly regulated by NF-κB and sustains NF-κB activation by decreasing Cylindromatosis expression
por: Cui, Xiaolu, et al.
Publicado: (2016) -
AB130. The expression and clinical significance of HIF-1α in bladder urothelial carcinoma
por: Fan, Haitao
Publicado: (2016)